ESMO Exclusive Interview | Dr.Changsong Qi: CAR-T Therapy IM96 Shows Significant Antitumor Activity in Advanced Colorectal Cancer with GCC Expression
Phase I study of GCC CAR-T therapy IM96 in patients with advanced colorectal cancer Background The clinical outcomes of metastatic colorectal cancer (mCRC) therapies are limited. Guanylyl cyclase 2C (GCC)…